Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carboxyl ester lipase (CEL), also known as bile salt-dependent lipase (BSDL) or bile salt-stimulated lipase (BSSL), is a glycoprotein enzyme primarily secreted by the pancreas and mammary gland. CEL plays a crucial role in lipid digestion and absorption, with broad substrate specificity for various lipid molecules including cholesteryl esters, triacylglycerols, phospholipids, and ceramides. Mutations in CEL are associated with Maturity-Onset Diabetes Of The Young type 8 (MODY8) and elevated serum levels are observed during acute pancreatitis.
Hydrolyzes ester bonds in various lipid substrates, requiring bile salts for optimal activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carboxyl ester lipase (CEL).